MeiraGTx Holdings (MGTX) Total Liabilities (2017 - 2025)
MeiraGTx Holdings posted quarterly Total Liabilities of $250.2 million for Q4 2025, up 23.92% year-on-year from $201.9 million in Q4 2024, and up 8.78% on a QoQ basis from $230.0 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 9 years of Total Liabilities data on file, last reported at $250.2 million in Q4 2025.
- For the quarter ending Q4 2025, Total Liabilities rose 23.92% year-over-year to $250.2 million; the trailing twelve-month figure through Dec 2025 stood at $250.2 million (up 23.92% YoY), and the FY2025 full-year result was $250.2 million, up 23.92% from the prior year.
- Total Liabilities for Q4 2025 stood at $250.2 million, up from $230.0 million in the prior quarter.
- Across five years, Total Liabilities topped out at $250.2 million in Q4 2025 and bottomed at $110.5 million in Q2 2022.
- The 5-year median for Total Liabilities is $187.1 million (2023), against an average of $175.1 million.
- The widest annual swing landed in 2022, when Total Liabilities decreased 8.72%; it then soared 69.01% in 2023.
- A 5-year view of Total Liabilities shows it stood at $134.8 million in 2021, then surged by 48.78% to $200.5 million in 2022, then declined by 5.95% to $188.6 million in 2023, then gained by 7.08% to $201.9 million in 2024, then climbed by 23.92% to $250.2 million in 2025.
- The last three Total Liabilities figures came in at $250.2 million (Q4 2025), $230.0 million (Q3 2025), and $195.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.05 Bn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 250.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 250.22 Mn |
| Sep 30, 2025 | 230.03 Mn |
| Jun 30, 2025 | 195.76 Mn |
| Mar 31, 2025 | 190.92 Mn |
| Dec 31, 2024 | 201.92 Mn |
| Sep 30, 2024 | 203.75 Mn |
| Jun 30, 2024 | 186.61 Mn |
| Mar 31, 2024 | 187.50 Mn |
| Dec 31, 2023 | 188.57 Mn |
| Sep 30, 2023 | 175.31 Mn |
| Jun 30, 2023 | 186.74 Mn |
| Mar 31, 2023 | 197.92 Mn |
| Dec 31, 2022 | 200.50 Mn |
| Sep 30, 2022 | 178.74 Mn |
| Jun 30, 2022 | 110.49 Mn |
| Mar 31, 2022 | 126.41 Mn |
| Dec 31, 2021 | 134.76 Mn |
| Sep 30, 2021 | 115.50 Mn |
| Jun 30, 2021 | 121.05 Mn |
| Mar 31, 2021 | 118.88 Mn |
| Dec 31, 2020 | 125.14 Mn |
| Sep 30, 2020 | 113.96 Mn |
| Jun 30, 2020 | 117.85 Mn |
| Mar 31, 2020 | 119.74 Mn |
| Dec 31, 2019 | 133.09 Mn |
| Sep 30, 2019 | 122.86 Mn |
| Jun 30, 2019 | 123.51 Mn |
| Mar 31, 2019 | 113.44 Mn |
| Dec 31, 2018 | 15.84 Mn |
| Sep 30, 2018 | 8.89 Mn |
| Jun 30, 2018 | 9.20 Mn |
| Mar 31, 2018 | 60.92 Mn |
| Dec 31, 2017 | 21.88 Mn |